Features of Extramedullary Disease of Multiple Myeloma: High Frequency of P53 Deletion and Poor Survival: A Retrospective Single-Center Study of 834 Cases
- 1 May 2015
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 15 (5), 286-291
- https://doi.org/10.1016/j.clml.2014.12.013
Abstract
No abstract availableKeywords
Funding Information
- the Natural Science Foundation of China (81172255, 81101794)
- National Public Health Grand Research Foundation (201202017)
This publication has 28 references indexed in Scilit:
- Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapseHaematologica, 2013
- Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapseLeukemia & Lymphoma, 2012
- Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agentsHaematologica, 2012
- Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaLeukemia, 2011
- Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?Leukemia Research, 2009
- Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patientsAnnals Of Oncology, 2009
- Bortezomib and extramedullary disease in multiple myeloma: The shine and dark side of the moonLeukemia Research, 2007
- Epidemiology of multiple myeloma in TaiwanCancer, 2007
- Presenting Features and Prognosis in 72 Patients With Multiple Myeloma Who Were Younger Than 40 YearsBritish Journal of Haematology, 1996
- Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.Journal of Clinical Oncology, 1994